APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Methylation Assay

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA Methylation Assay Market Outlook and Growth Opportunities 2026

16 April 2026Not stated

Choose your research edition.

Industry ResearchDNA Methylation Assay Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Methylation Assay Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal DNA Methylation Assay Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Methylation Assay Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal DNA Methylation Assay Market Analysis and Forecast 2026-2032180 pages · $4,950 USD

Market perspective

The global DNA Methylation Assay market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Methylation Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Methylation Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Methylation Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Methylation Assay market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Methylation Assay market include Illumina, Inc, Thermo Fisher Scientific, EpigenTek, GRAIL, New England Biolabs, Zymo Research, Diagenode, Agena Bioscience and EpigenDx, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global DNA Methylation Assay market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Methylation Assay and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Methylation Assay revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Methylation Assay market.

DNA Methylation Assay Segment by Company

Illumina, Inc

Thermo Fisher Scientific

EpigenTek

GRAIL

New England Biolabs

Zymo Research

Diagenode

Agena Bioscience

EpigenDx

DNA Methylation Assay Segment by Type

Loci-specific Methylation

Global Methylation

DNA Methylation Assay Segment by Application

Biopharmaceutical Companies

Research Institutions

Others

DNA Methylation Assay Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Methylation Assay status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA Methylation Assay key companies, revenue, market share, and recent developments.

3. To split the DNA Methylation Assay breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA Methylation Assay market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Methylation Assay significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Methylation Assay competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Methylation Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Methylation Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Methylation Assay.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Methylation Assay industry.

Chapter 3: Detailed analysis of DNA Methylation Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA Methylation Assay in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA Methylation Assay in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Methylation Assay Industry Trends Table 2. DNA Methylation Assay Industry Drivers Table 3. DNA Methylation Assay Industry Opportunities and Challenges Table 4. DNA Methylation Assay Industry Restraints Table 5. Global DNA Methylation Assay Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Methylation Assay Revenue Share by Company (2021-2026) Table 7. Global DNA Methylation Assay Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA Methylation Assay Key Company Manufacturing Base & Headquarters Table 9. Global DNA Methylation Assay Company, Product Type & Application Table 10. Global DNA Methylation Assay Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA Methylation Assay by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Loci-specific Methylation Table 15. Significant Companies of Global Methylation Table 16. Global DNA Methylation Assay Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global DNA Methylation Assay Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global DNA Methylation Assay Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global DNA Methylation Assay Sales Value Share by Type (2021-2026) Table 20. Global DNA Methylation Assay Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biopharmaceutical Companies Table 22. Significant Companies of Research Institutions Table 23. Significant Companies of Others Table 24. Global DNA Methylation Assay Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global DNA Methylation Assay Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global DNA Methylation Assay Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global DNA Methylation Assay Sales Value Share by Application (2021-2026) Table 28. Global DNA Methylation Assay Sales Value Share by Application (2027-2032) Table 29. Global DNA Methylation Assay Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global DNA Methylation Assay Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global DNA Methylation Assay Sales Value Share by Region (2021-2026) Table 32. Global DNA Methylation Assay Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global DNA Methylation Assay Sales Value Share by Region (2027-2032) Table 34. Global DNA Methylation Assay Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global DNA Methylation Assay Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global DNA Methylation Assay Sales Value Market Share by Country (2021-2026) Table 37. Global DNA Methylation Assay Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global DNA Methylation Assay Sales Value Market Share by Country (2027-2032) Table 39. Illumina, Inc Company Information Table 40. Illumina, Inc Business Overview Table 41. Illumina, Inc DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Illumina, Inc DNA Methylation Assay Product Portfolio Table 43. Illumina, Inc Recent Development Table 44. Thermo Fisher Scientific Company Information Table 45. Thermo Fisher Scientific Business Overview Table 46. Thermo Fisher Scientific DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Thermo Fisher Scientific DNA Methylation Assay Product Portfolio Table 48. Thermo Fisher Scientific Recent Development Table 49. EpigenTek Company Information Table 50. EpigenTek Business Overview Table 51. EpigenTek DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. EpigenTek DNA Methylation Assay Product Portfolio Table 53. EpigenTek Recent Development Table 54. GRAIL Company Information Table 55. GRAIL Business Overview Table 56. GRAIL DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. GRAIL DNA Methylation Assay Product Portfolio Table 58. GRAIL Recent Development Table 59. New England Biolabs Company Information Table 60. New England Biolabs Business Overview Table 61. New England Biolabs DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. New England Biolabs DNA Methylation Assay Product Portfolio Table 63. New England Biolabs Recent Development Table 64. Zymo Research Company Information Table 65. Zymo Research Business Overview Table 66. Zymo Research DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zymo Research DNA Methylation Assay Product Portfolio Table 68. Zymo Research Recent Development Table 69. Diagenode Company Information Table 70. Diagenode Business Overview Table 71. Diagenode DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Diagenode DNA Methylation Assay Product Portfolio Table 73. Diagenode Recent Development Table 74. Agena Bioscience Company Information Table 75. Agena Bioscience Business Overview Table 76. Agena Bioscience DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Agena Bioscience DNA Methylation Assay Product Portfolio Table 78. Agena Bioscience Recent Development Table 79. EpigenDx Company Information Table 80. EpigenDx Business Overview Table 81. EpigenDx DNA Methylation Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. EpigenDx DNA Methylation Assay Product Portfolio Table 83. EpigenDx Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. DNA Methylation Assay Product Image Figure 2. Global DNA Methylation Assay Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Methylation Assay Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Methylation Assay Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Loci-specific Methylation Image Figure 8. Global Methylation Image Figure 9. Global DNA Methylation Assay Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global DNA Methylation Assay Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global DNA Methylation Assay Sales Value Share by Type (2021-2032) Figure 12. Biopharmaceutical Companies Image Figure 13. Research Institutions Image Figure 14. Others Image Figure 15. Global DNA Methylation Assay Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global DNA Methylation Assay Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global DNA Methylation Assay Sales Value Share by Application (2021-2032) Figure 18. Global DNA Methylation Assay Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global DNA Methylation Assay Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America DNA Methylation Assay Sales Value (2021-2032) & (US$ Million) Figure 21. North America DNA Methylation Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe DNA Methylation Assay Sales Value (2021-2032) & (US$ Million) Figure 23. Europe DNA Methylation Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific DNA Methylation Assay Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific DNA Methylation Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America DNA Methylation Assay Sales Value (2021-2032) & (US$ Million) Figure 27. South America DNA Methylation Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa DNA Methylation Assay Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa DNA Methylation Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt DNA Methylation Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Loci-specific Methylation
  • Global Methylation
Applications
  • Biopharmaceutical Companies
  • Research Institutions
  • Others
Companies covered
  • Illumina, Inc
  • Thermo Fisher Scientific
  • EpigenTek
  • GRAIL
  • New England Biolabs
  • Zymo Research
  • Diagenode
  • Agena Bioscience
  • EpigenDx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Methylation Assay Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Methylation Assay Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA Methylation Assay Market Dynamics
  1. 2.1 DNA Methylation Assay Industry Trends
  2. 2.2 DNA Methylation Assay Industry Drivers
  3. 2.3 DNA Methylation Assay Industry Opportunities and Challenges
  4. 2.4 DNA Methylation Assay Industry Restraints
3 DNA Methylation Assay Market by Company
  1. 3.1 Global DNA Methylation Assay Company Revenue Ranking in 2025
  2. 3.2 Global DNA Methylation Assay Revenue by Company (2021-2026)
  3. 3.3 Global DNA Methylation Assay Company Ranking (2024-2026)
  4. 3.4 Global DNA Methylation Assay Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA Methylation Assay Company Product Type and Application
  6. 3.6 Global DNA Methylation Assay Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA Methylation Assay Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA Methylation Assay Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA Methylation Assay Market by Type
  1. 4.1 DNA Methylation Assay Type Introduction
  2. 4.1.1 Loci-specific Methylation
  3. 4.1.2 Global Methylation
  4. 4.2 Global DNA Methylation Assay Sales Value by Type
  5. 4.2.1 Global DNA Methylation Assay Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Methylation Assay Sales Value by Type (2021-2032)
  7. 4.2.3 Global DNA Methylation Assay Sales Value Share by Type (2021-2032)
5 DNA Methylation Assay Market by Application
  1. 5.1 DNA Methylation Assay Application Introduction
  2. 5.1.1 Biopharmaceutical Companies
  3. 5.1.2 Research Institutions
  4. 5.1.3 Others
  5. 5.2 Global DNA Methylation Assay Sales Value by Application
  6. 5.2.1 Global DNA Methylation Assay Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DNA Methylation Assay Sales Value by Application (2021-2032)
  8. 5.2.3 Global DNA Methylation Assay Sales Value Share by Application (2021-2032)
6 DNA Methylation Assay Regional Value Analysis
  1. 6.1 Global DNA Methylation Assay Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Methylation Assay Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA Methylation Assay Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA Methylation Assay Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Methylation Assay Sales Value (2021-2032)
  7. 6.3.2 North America DNA Methylation Assay Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA Methylation Assay Sales Value (2021-2032)
  10. 6.4.2 Europe DNA Methylation Assay Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA Methylation Assay Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA Methylation Assay Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA Methylation Assay Sales Value (2021-2032)
  16. 6.6.2 South America DNA Methylation Assay Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA Methylation Assay Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA Methylation Assay Sales Value Share by Country, 2025 VS 2032
7 DNA Methylation Assay Country-level Value Analysis
  1. 7.1 Global DNA Methylation Assay Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Methylation Assay Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA Methylation Assay Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA Methylation Assay Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA Methylation Assay Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA Methylation Assay Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA Methylation Assay Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina, Inc
  2. 8.1.1 Illumina, Inc Company Information
  3. 8.1.2 Illumina, Inc Business Overview
  4. 8.1.3 Illumina, Inc DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina, Inc DNA Methylation Assay Product Portfolio
  6. 8.1.5 Illumina, Inc Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific DNA Methylation Assay Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 EpigenTek
  14. 8.3.1 EpigenTek Company Information
  15. 8.3.2 EpigenTek Business Overview
  16. 8.3.3 EpigenTek DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  17. 8.3.4 EpigenTek DNA Methylation Assay Product Portfolio
  18. 8.3.5 EpigenTek Recent Developments
  19. 8.4 GRAIL
  20. 8.4.1 GRAIL Company Information
  21. 8.4.2 GRAIL Business Overview
  22. 8.4.3 GRAIL DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GRAIL DNA Methylation Assay Product Portfolio
  24. 8.4.5 GRAIL Recent Developments
  25. 8.5 New England Biolabs
  26. 8.5.1 New England Biolabs Company Information
  27. 8.5.2 New England Biolabs Business Overview
  28. 8.5.3 New England Biolabs DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  29. 8.5.4 New England Biolabs DNA Methylation Assay Product Portfolio
  30. 8.5.5 New England Biolabs Recent Developments
  31. 8.6 Zymo Research
  32. 8.6.1 Zymo Research Company Information
  33. 8.6.2 Zymo Research Business Overview
  34. 8.6.3 Zymo Research DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zymo Research DNA Methylation Assay Product Portfolio
  36. 8.6.5 Zymo Research Recent Developments
  37. 8.7 Diagenode
  38. 8.7.1 Diagenode Company Information
  39. 8.7.2 Diagenode Business Overview
  40. 8.7.3 Diagenode DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Diagenode DNA Methylation Assay Product Portfolio
  42. 8.7.5 Diagenode Recent Developments
  43. 8.8 Agena Bioscience
  44. 8.8.1 Agena Bioscience Company Information
  45. 8.8.2 Agena Bioscience Business Overview
  46. 8.8.3 Agena Bioscience DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Agena Bioscience DNA Methylation Assay Product Portfolio
  48. 8.8.5 Agena Bioscience Recent Developments
  49. 8.9 EpigenDx
  50. 8.9.1 EpigenDx Company Information
  51. 8.9.2 EpigenDx Business Overview
  52. 8.9.3 EpigenDx DNA Methylation Assay Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EpigenDx DNA Methylation Assay Product Portfolio
  54. 8.9.5 EpigenDx Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst